Addus HomeCare CorporationQ2 earnings report upcoming; analysts expect revenue growth slowdown, but prior EPS beat and price target above current price.
Addus HomeCare will report its second-quarter results after the market closes on Monday. Analysts expect revenue to grow 7.7% year on year, a slowdown from the 21.8% increase in the same quarter last year. The company missed revenue estimates last quarter, reporting $363.6 million, though it beat earnings per share expectations. Peers BrightSpring Health Services and Chemed have already reported Q2 results, with BrightSpring posting 23% revenue growth and Chemed 8.8%, both exceeding analyst forecasts. Addus HomeCare shares have risen 9.2% over the past month and enter earnings with an average analyst price target of $133, compared to a current price of $115.48.
Addus HomeCare CorporationQ2 earnings report upcoming; analysts expect revenue growth slowdown, but prior EPS beat and price target above current price.
BrightSpring Health Services, Inc. Common StockBrightSpring reported 23% revenue growth, exceeding forecasts, indicating strong demand.
Chemed CorpChemed reported 8.8% revenue growth, exceeding forecasts, indicating strong demand.